The present disclosure relates generally to medical treatment systems for treating wounds that produce liquids, such as exudate, and more particularly, but not by way of limitation, to reduced-pressure medical dressings, systems, and methods with evaporative devices.
Caring for wounds is important in the healing process. Wounds often produce considerable liquids, e.g., exudate. Medical dressings are often used in wound care to address the production of liquids from the wound. If not properly addressed, liquids at the wound can lead to infection or maceration of the periwound area. As used throughout this document, “or” does not require mutual exclusivity. Wound dressings may be used alone or as an aspect of applying reduced pressure to a tissue site.
Clinical studies and practice have shown that providing reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, which may include faster healing and increased formulation of granulation tissue.
According to an illustrative embodiment, an inline storage-and-liquid-processing pouch for use with body fluids from a patient is presented that involves introducing body fluids into a first chamber in the pouch and flowing air through a second chamber where the chambers are separated by a high-moisture-vapor-transfer-rate member. The air flow in the second chamber enhances liquid removal from the first chamber across the high-moisture-vapor-transfer-rate member.
According to another illustrative embodiment, a system for treating a tissue site on a patient with reduced-pressure includes a reduced-pressure dressing for disposing proximate to the tissue site, a first reduced-pressure conduit fluidly coupled to the reduced-pressure dressing for delivery reduced pressure thereto, and an inline storage-and-liquid-processing pouch having a first chamber and a second chamber. The first reduced-pressure conduit is fluidly coupled to the first chamber. The system further includes a reduced-pressure source fluidly coupled to the first chamber and a pressure source fluidly coupled to the second chamber at a first evaporation port. The system also includes a second evaporation port formed on the inline storage-and-liquid-processing pouch. The pressure source is configured to move air within the second chamber.
According to another illustrative embodiment, an inline storage-and-liquid-processing pouch for use with body fluids from a patient includes a pouch body having an interior portion divided into two parts by a first high-moisture-vapor-transfer-rate member to form a first chamber and a second chamber. The inline storage-and-liquid-processing pouch also includes a storage material disposed within the first chamber and an air-movement manifold disposed within the second chamber. The inline storage-and-liquid-processing pouch also includes a first port formed on the pouch body and fluidly coupled to the first chamber; a second port formed on the pouch body and fluidly coupled to the first chamber; a first evaporation port formed on the pouch body and fluidly coupled to the second chamber; and a second evaporation port formed on the pouch body and fluidly coupled to the second chamber.
According to another illustrative embodiment, a method for temporarily storing and processing body fluids outside of a patient includes providing an inline storage-and-liquid-processing pouch. The inline storage-and-liquid-processing pouch includes a pouch body having an interior portion divided into two parts by a first high-moisture-vapor-transfer-rate member to form a first chamber and a second chamber. The inline storage-and-liquid-processing pouch further includes a storage material disposed within the first chamber and an air-movement manifold disposed within the second chamber. The inline storage-and-liquid-processing pouch further includes a first port formed on the pouch body and fluidly coupled to the first chamber; a second port formed on the pouch body and fluidly coupled to the first chamber; a first evaporation port formed on the pouch body and fluidly coupled to the second chamber; and a second evaporation port formed on the pouch body and fluidly coupled to the second chamber. The method further includes delivering the body fluids, which include liquids, to the first port and into the first chamber and developing an airflow in the second chamber through the air-movement manifold. As a result, a humidity gradient is maintained across the first high-moisture-vapor-transfer-rate member to evaporate liquids from the first chamber.
According to still another illustrative embodiment, an inline storage-and-liquid-processing pouch for use with body fluids from a patient includes a pouch body having an interior portion divided into three parts by a first high-moisture-vapor-transfer-rate member and a second high-moisture-vapor-transfer-rate member to form a first chamber, a second chamber, and a third chamber. The first chamber is between the second and third chambers. The inline storage-and-liquid-processing pouch further includes a storage material disposed within the first chamber, a first air-movement manifold disposed within the second chamber, and a second air-movement manifold disposed within the second chamber. The inline storage-and-liquid-processing pouch also includes a first port formed on the pouch body and fluidly coupled to the first chamber; a second port formed on the pouch body and fluidly coupled to the first chamber; a first evaporation port formed on the pouch body and fluidly coupled to the second chamber; a second evaporation port formed on the pouch body and fluidly coupled to the second chamber; a third evaporation port formed on the pouch body and fluidly coupled to the third chamber; and a fourth evaporation port formed on the pouch body and fluidly coupled to the third chamber proximate to the second end.
Other aspects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
Referring now to the figures and primarily to
The depicted wound 103 at tissue site 102 is through epidermis 108 and into dermis 110. A reduced-pressure dressing 112 is disposed on the tissue site 102 and is operable to receive fluids from the tissue site 102. The reduced-pressure dressing 112 may be any type of dressing for receiving fluids from the patient, but is shown as a dressing with a wound-interface manifold 113 and a drape 115. Indeed, the reduced-pressure dressing 112 may involve only removing fluids from a body-fluid container, such as an ostomy bag. Fluids, including liquids, from the tissue site 102 are delivered through a reduced-pressure interface 114 to a first reduced-pressure conduit 116 that is fluidly coupled to the inline storage-and-liquid-processing pouch 106.
As an overview of the illustrative embodiment of the inline storage-and-liquid-processing pouch 106, the inline storage-and-liquid-processing pouch 106 includes a pouch body 118 formed with exterior walls 119 and having an interior portion 120 that divided into two parts by a first high-moisture-vapor-transfer-rate member 122. The exterior walls 119 and first high-moisture-vapor-transfer-rate member 122 form a first chamber 124 and a second chamber 126. A storage material 128 is disposed within the first chamber 124. An air-movement manifold 130 is disposed in the second chamber 126. These aspects of the inline storage-and-liquid-processing pouch 106 and others will be further described.
A first port 132 is formed on the pouch body 118 and fluidly coupled to the first chamber 124. A second port 134 is formed on the pouch body 118 and fluidly coupled to the first chamber 124. A first evaporation port 136 is formed on the pouch body 118 and is fluidly coupled to the second chamber 126. A second evaporation port 138 is formed on the pouch body 118 and fluidly coupled to the second chamber 126. Reduced pressure is applied to the second port directly by a reduced-pressure source, e.g., a micro-pump (see
Thus, liquids are pulled into the first chamber 124 as suggested by arrows 142 from the reduced-pressure dressing 112. A hydrophobic filter 135 or other device may be placed at the downstream port, i.e., the second port 134 in
The first high-moisture-vapor-transfer-rate member 122 may be formed from any material that allows vapor to egress but not liquids. “Moisture Vapor Transmission Rate” or “MVTR” represents the amount of moisture that can pass through a material in a given period of time. The first high-moisture-vapor-transfer-rate member 122 typically has a moisture vapor transmission rate greater than 300 g/m2/24 hours and more typically 1000 g/m2/24 hours or more. The first high-moisture-vapor-transfer-rate member 122 allows vapor to egress or diffuse from the first chamber 124 to the second chamber 126, but not liquids.
The first high-moisture-vapor-transfer-rate member 122 may comprise one or more of the following: hydrophilic polyurethane, cellulosics, hydrophilic polyamides, an INSPIRE 2301 material from Exopack Advanced Coatings of Wrexham, United Kingdom; a thin, uncoated polymer drape; or polyvinyl alcohol, polyvinyl pyrrolidone, hydrophilic acrylics, hydrophilic silicone elastomers and copolymers of these. The INSPIRE 2301 illustrative film has an MVTR (inverted cup technique) of 14500-14600 g/m2/24 hours. See www.exopackadvancedcoatings.com. The first high-moisture-vapor-transfer-rate member 122 may have various thicknesses, such as 10 to 40 microns (μm), e.g., 15, 20, 25, 30, 35, 40 microns (inclusive of all numbers in the stated range).
A patient-facing side 123 of the first high-moisture-vapor-transfer-rate member 122 may be coupled by an attachment device (not shown), e.g., adhesive or cement, to the top side (for the orientation shown in
The air flow in the second chamber 126 may be achieved in either direction and is shown in
The pouch body 118 may be formed in numerous ways. According to one illustrative embodiment, the exterior walls 119 are formed by a first sealing member 148 and a second sealing member 150. The first sealing member 148 is bonded by bond 149 to the second sealing member 150 at peripheral ends 152. The first high-moisture-vapor-transfer-rate member 122 is disposed between the first sealing member 148 and second sealing member 150 and may be bonded with bonds 149 as well. The first high-moisture-vapor-transfer-rate member 122 thereby forms two parts or bisects (not necessarily equal parts) the interior portion 120 to form the first chamber 124 and the second chamber 126.
The first sealing member 148 is formed from any material that inhibits air flow through the first sealing member 148 and typically that is liquid impermeable as well. In some embodiments, the first sealing member 148 may be a high-moisture-vapor-transfer-rate material to allow additional liquid to egress the second chamber 126. The second sealing member 150 is formed from any liquid-impermeable material. Typically, the first sealing member 148 and second sealing member 150 are formed from one or more of the following: natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, silicones, silicone drape, a 3M Tegaderm® drape, or a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif., or any material mentioned for the first high-moisture-vapor-transfer-rate member 122, or other appropriate material. The first sealing member 148 need not be liquid impermeable and could also be formed from a woven or non-woven material as long as the material is coated or constructed to contain the air flow.
The ports 132, 134, 136, and 138 are formed through the pouch body 118. Typically, the respective pairs of ports (132 and 132; 136 and 138) are displaced as far as possible from each other to maximize distribution of liquids or evaporation. Thus for example, typically the first port 132 is positioned on a first end 154 of the pouch body 118 and the second port 134 is positioned on the second end 156. Likewise, the first evaporation port 136 is on the first end 154 and the second evaporation port 138 is on the second end 156.
The storage material 128 is disposed in the first chamber 124. The storage material 128 is any material that receives fluids, including liquids, and retains the fluids. For example, without limitation, the storage material 128 may be formed from one or more of the following: an absorbent member 158, a first wicking member 160, a second wicking member 162. In the illustrative embodiment of
The absorbent member 158 may be any material that retains liquids and may comprise one or more of the following: BASF 402c, Technical Absorbents 2317, sodium polyacrylate super absorbers, cellulosics (carboxy methyl cellulose and salts such as sodium CMC), or alginates. The first wicking member 160 and second wicking member 162 may be formed from one or more of the following: non-woven fabrics such as Libeltex TDL2, woven fabrics including 3D spacer fabrics and Textiles (Baltex, Ilkeston, Derby, UK), open-cell foam, or sintered polymers.
In the illustrative embodiment of
Referring now to
Similarly, a second micro-pump 166 is coupled to the pouch body 118 and fluidly coupled to the second evaporation port 138. The second micro-pump 166 is operable to produce air flow in the second chamber 126 between the first evaporation port 136 and the second evaporation port 138. The second micro-pump 166 is analogous to the first micro-pump but may configured to either pull air as shown and suggested by arrows 168 or to push air. In the latter situation, air goes from the second evaporation port 138 through the second chamber 126 to the first evaporation port 136. The inline storage-and-liquid-processing pouch 106 may be formed with one or both of the micro-pumps 164, 166 or with one or more conduits 140, 146 as shown in
Referring now primarily to
It should be noted that that the inline storage-and-liquid-processing pouch 106 may take many different shapes. Some embodiments of the inline storage-and-liquid-processing pouch 106 are for wearing on the patient and others may be for a stationary position near the patient. In some embodiments, the second chamber 126 may encircle the first chamber 124 or other configurations may be used. The pouch body 118 may take different sizes too. In one illustrative embodiment, the pouch body 118 has surface area in plan view greater than 200 centimeters2 and less than 730 centimeters2.
In the embodiment of
Referring now primarily to
A pouch body 118 is formed having exterior walls 119. The pouch body 118 is partitioned by a first high-moisture-vapor-transfer-rate member 122 and a second high-moisture-vapor-transfer-rate member 174 to form the first chamber 124, a second chamber 126, and a third chamber 176. The second high-moisture-vapor-transfer-rate member 174 may formed from the same materials as the first high-moisture-vapor-transfer-rate member 122 as previously presented. The first chamber 124 is between the second chamber 126 and third chamber 176. As with previous embodiments, a storage material 128 is disposed within the first chamber 124 and an air-movement manifold 130, which is a first air-movement manifold 178, is disposed within the second chamber 126. In addition, a second air-movement manifold 180 is disposed in the third chamber 176. The first air-movement manifold 178 and second air-movement manifold 180 are formed from one or more of the same materials previously mentioned for the first air-movement manifold 130 in
The storage material 128 may be any of the materials previously mentioned.
Referring primarily to
Referring generally to
An air flow is produced in the second chamber 126 as suggested by arrows 144. Air may flow to or from the first evaporation port 136 and from or to the second evaporation port 138. The air flow in second chamber 126 is caused by applying positive or reduced pressure to one of the evaporation ports 136, 138. In addition, an air flow is produced in the third chamber 176 as suggested by arrows 186. Air may flow to or from the third evaporation port 182 and from or to the fourth evaporation port 184. The flow in third chamber 176 is caused by applying positive or reduced pressure to one of the evaporation ports 182, 184. In this way, air flowing on both sides of the first chamber 124 enhances the inline storage-and-liquid-processing pouch 106's ability to process liquids out of the inline storage-and-liquid-processing pouch 106.
In all the embodiments herein, the air movement through the second chamber 126 (and third chamber 176 when applicable) may be continuous, intermittent, or actively controlled. In the latter situation, a saturation sensor may be applied in the first chamber 124 or an outward facing side of the high-moisture-vapor-transfer-rate members 122, 174. The saturation sensor may be any device that allows monitoring of the saturation status of the storage material 128. For example, without limitation, the saturation sensor may be a resistive element that changes resistance when liquid covers the sensor, a galvanic cell that creates a voltage when covered with liquid from a wound, a capacitive sensor that changes properties when saturated liquid is nearby, or any other electrical saturation sensor. The saturation sensor is coupled to a controller, and the controller and saturation sensor determine when the storage material 128 or high-moisture-vapor-transfer-rate members 122, 174 are saturated. Upon detecting the same, the controller may activate a pressure source that supplies either reduced pressure or positive pressure to one of the evacuation ports 136, 138. When the saturation sensor and controller determine that the storage material 128 is not saturated, the controller may deactivate the pressure source.
In another illustrative embodiment, an inline storage-and-liquid-processing pouch 106 is coupled directly to a body-fluid bag, e.g., an ostomy bag. The inline storage-and-liquid-processing pouch 106 may form an outer wall of the fluid-bag itself.
The illustrative systems and inline storage-and-liquid-processing pouches presented herein offer a number of perceived advantages. These include the ability to manage a higher volume of fluid than otherwise possible. In this regard, one may consider that exudate from a wound often has about 88 percent water and 12 percent other materials. With such a device in use, the system may not need changing for a relatively extended period of time. In addition, the inline storage-and-liquid-processing pouch is multi-directional and involves fewer parts than canisters in use. In addition, the inline storage-and-liquid-processing pouch has a low profile and is light. These are only some of the potential advantages.
Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment.
It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to “an” item refers to one or more of those items.
The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.
Where appropriate, aspects of any of the embodiments described above may be combined with aspects of any of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.
It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.
The present invention is a continuation of U.S. patent application Ser. No. 15/845,269, entitled “EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS,” filed Dec. 18, 2017, which is a continuation of U.S. patent application Ser. No. 14/860,165, entitled “EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS,” filed Sep. 21, 2015, now U.S. Pat. No. 9,877,873, which is a continuation of U.S. patent application Ser. No. 13/442,567, entitled “EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS,” filed Apr. 9, 2012, now U.S. Pat. No. 9,314,377, which is a continuation-in-part of U.S. patent application Ser. No. 13/084,813, entitled “DRESSINGS AND METHODS FOR TREATING A TISSUE SITE ON A PATIENT,” filed on Apr. 12, 2011, now U.S. Pat. No. 8,604,265, and incorporated herein by reference, which claims the benefit, under 35 USC § 119(e), of the filings of U.S. Provisional Application No. 61/359,181, entitled “DRESSINGS AND METHODS FOR TREATING A TISSUE SITE ON A PATIENT,” filed Jun. 28, 2010; U.S. Provisional Application No. 61,359,205, entitled “EVAPORATIVE BODY FLUID CONTAINERS AND METHODS,” filed Jun. 28, 2010; and U.S. Provisional Application No. 61/325,115, entitled “REDUCED-PRESSURE SOURCES, SYSTEMS, AND METHODS EMPLOYING A POLYMERIC, POROUS, HYDROPHOBIC MATERIALS,” filed Apr. 16, 2010, all of which are incorporated herein by reference. U.S. patent application Ser. No. 13/442,567 also claims the benefit, under 35 USC § 119(e), of the filings of: U.S. Provisional Patent Application Ser. No. 61/529,709, entitled “EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS,” filed Aug. 31, 2011, which is incorporated herein by reference for all purposes; U.S. Provisional Patent Application Ser. No. 61/529,722, entitled “REDUCED-PRESSURE DRESSINGS, SYSTEMS, AND METHODS WITH EVAPORATIVE DEVICES,” filed Aug. 31, 2011, which is incorporated herein by reference for all purposes; U.S. Provisional Patent Application Ser. No. 61/529,735, entitled “ABSORBENT POLYMER DRESSINGS, SYSTEMS, AND METHODS EMPLOYING EVAPORATIVE DEVICES,” filed Aug. 31, 2011, which is incorporated herein by reference for all purposes; and U.S. Provisional Patent Application Ser. No. 61/529,751, entitled “REDUCED-PRESSURE INTERFACES, SYSTEMS, AND METHODS EMPLOYING A COANDA DEVICE,” filed Aug. 31, 2011, all of which are incorporated herein by reference for all purposes.
Number | Date | Country | |
---|---|---|---|
61529709 | Aug 2011 | US | |
61529722 | Aug 2011 | US | |
61529735 | Aug 2011 | US | |
61529751 | Aug 2011 | US | |
61359181 | Jun 2010 | US | |
61359205 | Jun 2010 | US | |
61325115 | Apr 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15845269 | Dec 2017 | US |
Child | 17195330 | US | |
Parent | 14860165 | Sep 2015 | US |
Child | 15845269 | US | |
Parent | 13442567 | Apr 2012 | US |
Child | 14860165 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13084813 | Apr 2011 | US |
Child | 13442567 | US |